C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing therapies to degrade disease-causing proteins and thereby treat cancer, neurodegenerative conditions, and other diseases. The company uses its TORPEDO platform to synthesize targeted small molecule protein degraders, which employ a natural protein disposal system to catalyze the destruction of target proteins. C4 Therapeutics has strategic collaborations with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2015 and is headquartered in Watertown, MA.
What is C4 Therapeutics's quote symbol?
What is the 52 week high and low for C4 Therapeutics (NASDAQ: CCCC)?
How much is C4 Therapeutics stock worth today?
How much is C4 Therapeutics's stock price per share?
What is C4 Therapeutics's Market Cap?